Navigation Links
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
Date:9/9/2009

ctual or potential competitors or to the Company's ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries, including without limitation the litigation and claims referred to in Note 16 of the Notes to the Consolidated Financial Statements in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and under the heading "Certain Other Matters" in the Company's Form 8-K filed with the SEC on April 30, 2009; (16) the possibility that the Company's current estimates of the financial effect of certain announced product recalls could prove to be incorrect; (17) whether any product recalls or product introductions result in litigation, agency action or material damages; (18) the possibility that the findings of the Audit Committee inquiry referenced in the Company's Form 10-Q for the quarter ended June 30, 2008, Form 12b-25 filed with the SEC on November 13, 2008, Form 12b-25 filed with the SEC on February 2, 2009, Form 12b-25 filed with the SEC on June 6, 2009, Form 8-K filed with the SEC on June 23, 2009, as well as certain other of the Company's SEC filings, could have a material impact on the Company's financial results; (19) the satisfaction or waiver of the other closing conditions in the previously disclosed Gestiva(TM) acquisition agreement; (20) the possibility that the auction rate securities held by the Company may not return to liquidity at their face value; (21) the consent decree between the Company and the FDA and the Company's suspension of the production and shipment of substantially all of the products that the Company manufactures and the related nationwide recall affecting substantially all of the products that the Company manufactures, as well as the expected material adverse effect on the Company's revenue, assets and liquidity and capital re
'/>"/>
SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
2. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
3. FDA pharmaceutical import alert
4. KV Pharmaceutical Appoints Interim Chief Financial Officer
5. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
6. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
9. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
10. Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
11. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... current state of the global Sterilizers industry with a ... statistics on the market status of the Sterilizers manufacturers ... for companies and individuals interested in the industry. This ... its definition, applications and manufacturing technology. In this part, ...
(Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the business ... company announces big discounts on its bamboo mats ... BambooFlooringChina.com is the world’s leader in bamboo flooring. According ... Jan. 20, 2015. , The bamboo mats are made ... thread. All the bamboo strips for the mats are ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... continue to move forward in a number of multidistrict ... of West Virginia, Bernstein Liebhard LLP reports. According to ... is scheduled to convene a Joint Status Conference in ... 10:00 a.m. Parties have been directed to submit a ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
... The University of Colorado Cord Blood Bank, a component ... Medicine, has been awarded $6.3 million to collect and bank ... groups. The three-year grant is from the Health ... Department of Health and Human Services. Umbilical cord blood, collected ...
... back to the cancer communities in the cities visited ... Radiation Oncology (ASTRO) is partnering with the Emilio Nares ... survivorship issues., "When a child has cancer the entire ... a radiation oncologist at Massachusetts General Hospital, said. "The ...
... Hospital study has demonstrated how the hospital has improved patient ... transfusions. In 2009, the average amount of blood products transfused ... was in 2008, saving $453,355. The average amount of blood ... to 1.82 units per patient in 2009. Results were reported ...
... National Institute of Allergy and Infectious Diseases (NIAID), part ... new contracts to fund research on vaccines to protect ... be used in a terror attack. Each project focuses ... be deployed quickly. The total funding for the three ...
... HealthDay Reporter , WEDNESDAY, Oct. 6 (HealthDay News) -- A ... plus kidney failure did not show any overall benefit, indicating that ... "I think this is the end of the story for this ... in the Oct. 7 issue of the New England Journal ...
... 2010) To mark World Menopause Day on 18th ... new Recommendations for the management of postmenopausal vaginal atrophy, ... of women after menopause. This new guidance is ... women with vaginal atrophy (VA) will live with their ...
Cached Medicine News:Health News:University of Colorado gets federal award for Cord Blood Bank 2Health News:Reducing blood transfusions improves patient safety and cuts costs 2Health News:NIH funds advanced development of 3 biodefense vaccines 2Health News:NIH funds advanced development of 3 biodefense vaccines 3Health News:Once-Promising Heart Failure Drug Fails in Trial 2Health News:International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women 2Health News:International Menopause Society calls upon medical community to improve the vaginal health of postmenopausal women 3
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/24/2014)... HILL, N.C. , Dec. 23, 2014  Medical ... success. As the key link between the medical device ... grow even more in the coming years as the ... According to research by benchmarking firm, ... MSLs can gain an important edge is by harnessing ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Role of Medical Science Liaisons Evolving in Medical Device Sector 2
... Life Sciences, Inc. (Nasdaq: CALP ), a ... and life sciences research, today announced that the company ... for the Environmental Protection Agency,s (EPA) Phase II ToxCast™ ... Protection Agency (EPA) announced the next phase of toxicity ...
... 2010 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... diseases associated with inflammation, today announced that their product ... Pediatric Research Award at the Third Congress of the ... where Dr. Daniele De Luca, MD, PhDst at the ...
Cached Medicine Technology:Caliper Continues Participation in EPA's Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter 2Caliper Continues Participation in EPA's Expanded ToxCast Program; Receives Remaining Phase II Compounds for Screening in Fourth Quarter 3Varespladib Receives 2010 European Society Pediatric Research Award 2Varespladib Receives 2010 European Society Pediatric Research Award 3
The INSIGNIA® pacing systems allow the physician to provide customized adaptive-rate pacing therapy to meet individual patient needs....
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
... small portable unit weighing less than thirty ... dependability and uncompromising image quality. Compatible with ... is a cost effective solution for a ... keyboard is durable and easy to operate. ...
The EUB-525 is a mid-size system with a full feature set. Capable of B-mode, M-mode, Doppler, Color Flow and Color Angiography it performs a variety of tasks in a simple and straightforward fashion....
Medicine Products: